Calum D. Moulton

1.6k total citations · 1 hit paper
36 papers, 1.1k citations indexed

About

Calum D. Moulton is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Calum D. Moulton has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Calum D. Moulton's work include Cardiac Health and Mental Health (8 papers), Microscopic Colitis (8 papers) and Inflammatory Bowel Disease (7 papers). Calum D. Moulton is often cited by papers focused on Cardiac Health and Mental Health (8 papers), Microscopic Colitis (8 papers) and Inflammatory Bowel Disease (7 papers). Calum D. Moulton collaborates with scholars based in United Kingdom, United States and Norway. Calum D. Moulton's co-authors include Khalida Ismail, John C. Pickup, Daniel Ståhl, Paul Horton, Cynthia H.Y. Fu, Sergi G. Costafreda, Stephanie A. Amiel, Nick Powell, Bu Hayee and Christine Norton and has published in prestigious journals such as Gastroenterology, PLoS ONE and Diabetes Care.

In The Last Decade

Calum D. Moulton

34 papers receiving 1.1k citations

Hit Papers

The link between depression and diabetes: the search for ... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Calum D. Moulton United Kingdom 14 386 271 192 177 158 36 1.1k
María Lilia López‐Narváez Mexico 21 191 0.5× 164 0.6× 210 1.1× 111 0.6× 91 0.6× 122 1.5k
Daniel Kopf Germany 21 397 1.0× 155 0.6× 121 0.6× 282 1.6× 208 1.3× 77 1.3k
Thelma Beatriz González‐Castro Mexico 20 119 0.3× 106 0.4× 217 1.1× 120 0.7× 64 0.4× 134 1.5k
Klaus-Jürgen Gräf Germany 24 652 1.7× 264 1.0× 127 0.7× 127 0.7× 75 0.5× 48 1.7k
Laura E. Dichtel United States 22 383 1.0× 490 1.8× 36 0.2× 298 1.7× 176 1.1× 50 1.7k
Chris Bushe United Kingdom 26 409 1.1× 164 0.6× 100 0.5× 295 1.7× 113 0.7× 53 1.9k
D Van Eyck Belgium 16 663 1.7× 146 0.5× 80 0.4× 371 2.1× 110 0.7× 33 1.4k
Paul Mackin United Kingdom 17 248 0.6× 53 0.2× 151 0.8× 141 0.8× 150 0.9× 34 1.1k
Kai G. Kahl Germany 19 110 0.3× 60 0.2× 216 1.1× 140 0.8× 119 0.8× 60 1.2k
Bom-Taeck Kim South Korea 18 153 0.4× 108 0.4× 80 0.4× 237 1.3× 40 0.3× 50 1.3k

Countries citing papers authored by Calum D. Moulton

Since Specialization
Citations

This map shows the geographic impact of Calum D. Moulton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calum D. Moulton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calum D. Moulton more than expected).

Fields of papers citing papers by Calum D. Moulton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calum D. Moulton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calum D. Moulton. The network helps show where Calum D. Moulton may publish in the future.

Co-authorship network of co-authors of Calum D. Moulton

This figure shows the co-authorship network connecting the top 25 collaborators of Calum D. Moulton. A scholar is included among the top collaborators of Calum D. Moulton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calum D. Moulton. Calum D. Moulton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Moulton, Calum D., et al.. (2025). Effect of Buspirone on Upper Gastrointestinal Disorders of Gut–Brain Interaction: A Systematic Review and Meta-analysis. Journal of Neurogastroenterology and Motility. 31(1). 18–27. 1 indexed citations
3.
Moulton, Calum D., Allan H. Young, & Ailsa Hart. (2024). Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series. Clinical Gastroenterology and Hepatology. 22(8). 1737–1740. 3 indexed citations
4.
Moulton, Calum D., et al.. (2023). All-or-Nothing Behavior and Catastrophic Thinking Predict Fatigue in Inflammatory Bowel Disease: A Prospective Cohort Study. Inflammatory Bowel Diseases. 30(10). 1903–1906. 5 indexed citations
5.
6.
Powell, Nick, et al.. (2021). Cognitive Impairment in Adult Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Journal of the Academy of Consultation-Liaison Psychiatry. 62(4). 387–403. 28 indexed citations
7.
Moulton, Calum D., et al.. (2021). SITAgliptin for Depressive Symptoms in Type 2 Diabetes: A Feasibility Randomized Controlled Trial. Psychosomatic Medicine. 83(8). 913–923. 5 indexed citations
8.
Moulton, Calum D., Rebecca Strawbridge, Dimosthenis Tsapekos, et al.. (2020). The Maudsley 3-item Visual Analogue Scale (M3VAS): Validation of a scale measuring core symptoms of depression. Journal of Affective Disorders. 282. 280–283. 13 indexed citations
9.
Moulton, Calum D., et al.. (2020). The psychopathology of recurrent diabetic ketoacidosis: A case–control study. Diabetic Medicine. 38(7). e14505–e14505. 8 indexed citations
10.
Moulton, Calum D., et al.. (2019). The Prospective Association Between Inflammation and Depressive Symptoms in Type 2 Diabetes Stratified by Sex. Diabetes Care. 42(10). 1865–1872. 9 indexed citations
11.
Moulton, Calum D., Laura Murray, Kirsty Winkley, et al.. (2019). Depression and change in occupational functioning in type 2 diabetes. Occupational Medicine. 69(5). 322–328. 5 indexed citations
12.
Moulton, Calum D., et al.. (2018). Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials. Psychoneuroendocrinology. 94. 91–103. 62 indexed citations
13.
Moulton, Calum D. & John C. Pickup. (2018). Innate immunity and inflammation in type 2 diabetes-associated depression. Oxford University Press eBooks. 1 indexed citations
14.
Ismail, Khalida, Calum D. Moulton, Kirsty Winkley, et al.. (2017). The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study. Diabetologia. 60(10). 2092–2102. 58 indexed citations
15.
Moulton, Calum D., et al.. (2017). Effects of incretin-based therapies on neurocognitive function in humans: A systematic review of the literature. Primary care diabetes. 12(1). 51–58. 11 indexed citations
16.
Moulton, Calum D., et al.. (2016). The prevalence of depression and its correlates in ankylosing spondylitis: A systematic review and meta-analysis. European Psychiatry. 33(S1). S148–S149. 7 indexed citations
17.
Moulton, Calum D., John C. Pickup, & Khalida Ismail. (2015). The link between depression and diabetes: the search for shared mechanisms. The Lancet Diabetes & Endocrinology. 3(6). 461–471. 477 indexed citations breakdown →
18.
Moulton, Calum D., et al.. (2015). Factors associated with cognitive impairment in patients with newly diagnosed type 2 diabetes: a cross-sectional study. Aging & Mental Health. 20(8). 840–847. 18 indexed citations
19.
Moulton, Calum D. & Ivan Koychev. (2014). The effect of penicillin therapy on cognitive outcomes in neurosyphilis: a systematic review of the literature. General Hospital Psychiatry. 37(1). 49–52. 10 indexed citations
20.
Eade, O.E., et al.. (1980). Lymphocyte subpopulations of intestinal mucosa in inflammatory bowel disease.. Gut. 21(8). 675–682. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026